Your browser doesn't support javascript.
loading
Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.
Jones, Jefferson M; Gurbaxani, Brian M; Asher, Alice; Sansom, Stephanie; Annambhotla, Pallavi; Moorman, Anne C; Kamili, Saleem; Brooks, John T; Basavaraju, Sridhar V.
Affiliation
  • Jones JM; Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Gurbaxani BM; Office of Science and H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Asher A; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Sansom S; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Annambhotla P; Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Moorman AC; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kamili S; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Brooks JT; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Basavaraju SV; Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Am J Transplant ; 19(9): 2583-2593, 2019 09.
Article in En | MEDLINE | ID: mdl-30980600
ABSTRACT
To reduce the risk of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) transmission through organ transplantation, donors are universally screened for these infections by nucleic acid tests (NAT). Deceased organ donors are classified as "increased risk" if they engaged in specific behaviors during the 12 months before death. We developed a model to estimate the risk of undetected infection for HIV, HBV, and HCV among NAT-negative donors specific to the type and timing of donors' potential risk behavior to guide revisions to the 12-month timeline. Model parameters were estimated, including risk of disease acquisition for increased risk groups, number of virions that multiply to establish infection, virus doubling time, and limit of detection by NAT. Monte Carlo simulation was performed. The risk of undetected infection was <1/1 000 000 for HIV after 14 days, for HBV after 35 days, and for HCV after 7 days from the time of most recent potential exposure to the day of a negative NAT. The period during which reported donor risk behaviors result in an "increased risk" designation can be safely shortened.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / HIV Infections / Organ Transplantation / Hepatitis C / Risk Assessment / Hepatitis B Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2019 Document type: Article Affiliation country: Georgia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / HIV Infections / Organ Transplantation / Hepatitis C / Risk Assessment / Hepatitis B Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2019 Document type: Article Affiliation country: Georgia